NIDDK


Also found in: Medical.
AcronymDefinition
NIDDKNational Institute of Diabetes and Digestive and Kidney Diseases
References in periodicals archive ?
Mark Pruzanski, MD, founder, President and CEO of Intercept, commented, "We are excited to collaborate with the NIDDK and CRN to test our drug in such a robust NASH study.
population, NIDDK has sponsored a number of large, multicenter studies of specific kidney disorders.
Research has clearly shown that losing five to seven percent of body weight through diet and increased physical activity can prevent or delay pre-diabetes from progressing to type 2 diabetes," explains NIDDK director Allen Spiegel.
Publications produced by the clearinghouse are carefully reviewed by both NIDDK scientists and outside experts.
We are excited that the NIDDK has selected our technology to carry out this important work," said Erik Wallden, President and CEO of Pyrosequencing AB.
In addition, studies that exploit the zebrafish to model physiological processes such as renal function, fluid and electrolyte balance, are relevant to NIDDK.
Liu notes that the NIDDK team turned up no gender differences in the hypothalamus, the brain area responsible for basic physiological responses to hunger and satiation.
It's gratifying to see progress, however small, and to know that NIDDK activities undoubtedly have had a hand in that success," said Paul W.
The specific objectives of this announcement on Secondary Analyses In Obesity, Diabetes, Digestive And Kidney Diseases are to support the following: (a) research on secondary analyses of data related to the epidemiology of disease areas of NIDDK; (b) preliminary projects using secondary analysis that could lead to subsequent applications for individual research awards; (c) rapid analyses of new databases and experimental modules to inform the design and content of future studies; (d) the archiving of data sets to be made publicly available for research purposes related to disease areas of NIDDK, including both epidemiological studies and multi-center clinical trials.
It is gratifying to see progress, however small, and to know that NIDDK activities undoubtedly have had a hand in that success," said Paul Eggers, PhD, the NIDDK co-director of the US Renal Data System (USRDS).
gov; James Hyde, Division of Diabetes, Endocrinology, and Metabolic Diseases, NIDDK, 6707 Democracy Blvd, Rm 609, MSC 5460, Bethesda, MD 20892-5460 USA, 301-594-7692, e-mail: jh486z@nih.